2021-12-25 D. 教學1F 第五會議室
時間主題講者座長簡報錄影
10:15 ~ 10:40
The importance of quality of survival in the evolving nmCRPC landscape
Fred Saad
歐宴泉,
王賢祥
10:40 ~ 11:05
Beyond AR targeted agents, the emerging novel treatments for mCRPC
Ketan Badani
歐宴泉,
王賢祥
11:05 ~ 11:30
Final analysis from TITAN: A phase III study of apalutamide versus placebo in patients with mCSPC receiving ADT
Kim Nguyen Chi
歐宴泉,
王賢祥